Stay updated on Pembrolizumab in Recurrent Ovarian Cancer Clinical Trial
Sign up to get notified when there's something new on the Pembrolizumab in Recurrent Ovarian Cancer Clinical Trial page.
Latest updates to the Pembrolizumab in Recurrent Ovarian Cancer Clinical Trial page
- Check7 days agoChange DetectedThe website has updated to version v2.13.3, adding 'Results Submitted' while removing 'No Results Posted' from the previous version v2.13.2.SummaryDifference0.5%
- Check14 days agoChange DetectedThe website has updated the contact details section for the study, clarifying that it now provides information for individuals who can answer questions about joining the study and includes a reference to the Contacts and Locations section.SummaryDifference2%
- Check21 days agoNo Change Detected
- Check28 days agoChange DetectedThe website has added new features, while several detailed data fields and options for downloading study information have been removed.SummaryDifference4%
- Check36 days agoChange DetectedSeveral key health-related links, including those for ovarian cancer and related resources, have been removed from the website.SummaryDifference0.6%
- Check43 days agoChange DetectedThe website has been updated to version 2.12.2, with numerous new links added related to ovarian cancer and treatment options, while the previous version 2.12.1 has been removed.SummaryDifference4%
- Check50 days agoChange DetectedThe website has been updated from version v2.12.0 to v2.12.1.SummaryDifference0.1%
Stay in the know with updates to Pembrolizumab in Recurrent Ovarian Cancer Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Pembrolizumab in Recurrent Ovarian Cancer Clinical Trial page.